Silence unveils more PhI data for siRNA drug in new cardiovascular race targeting Lp(a)news2023-11-01T14:45:30+00:00November 1st, 2023|Endpoints News|
‘Small molecules are sexy again’: Gate Bioscience debuts with $60M and a new way to stop disease-causing proteinsnews2023-11-01T14:02:40+00:00November 1st, 2023|Endpoints News|
AbbVie seeks Restasis follow-up with small option fee for Aldeyra’s eye drops, despite a potential ‘imminent’ CRLnews2023-11-01T13:30:29+00:00November 1st, 2023|Endpoints News|
Padcev plus Keytruda data raise efficacy expectations in current and future urothelial cancer trialsnews2023-11-01T12:29:26+00:00November 1st, 2023|Endpoints News|
Eli Lilly and Boehringer Ingelheim pay tribute to hip-hop anniversary in chronic kidney disease campaign with Rob Basenews2023-11-01T12:00:15+00:00November 1st, 2023|Endpoints News|
GSK’s Arexvy marks its territory in US RSV market, company cuts three early-stage assetsnews2023-11-01T11:34:40+00:00November 1st, 2023|Endpoints News|
AI drug designer Generate:Biomedicines partners with Roswell Park on cell therapy for solid tumorsnews2023-11-01T10:00:58+00:00November 1st, 2023|Endpoints News|
Apnimed and Shionogi create $150M joint venture for sleep apneanews2023-11-01T08:00:49+00:00November 1st, 2023|Endpoints News|
ViroCell to operate from a London facility to manufacture viral vectors for clinical trialsnews2023-11-01T07:00:33+00:00November 1st, 2023|Endpoints News|
Updated: European Commission authorizes Novavax’s updated Covid vaccinenews2023-10-31T18:32:07+00:00October 31st, 2023|Endpoints News|
